Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy

K. L. Womer, J. R. Stone, B. Murphy, A. Chandraker, M. H. Sayegh

Research output: Contribution to journalArticle

Abstract

Recent clinical and experimental evidence suggests that indirect allorecognition may promote the development of chronic rejection, but definitive experimental studies are lacking. To study the contribution of indirect allorecognition to chronic rejection, naïve Lewis (RT1l) rats were immunized with synthetic Wistar Furth (WF) class II-RT1u.D (HLA-DR-like) or -RT1U.B (HLA-DQ-like) or class I-RT1u.A (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n = 5 to 7/group). Experimental and control animals then acted as recipients of fully mismatched WF vascularized cardiac allografts. Recipients received immunosuppression in the form of cyclosporine at a tapering dose that allows for long-term allograft survival. Animals were sacrificed at either 3 or 6 mo, with allograft arterial luminal occlusion scored on elastin stains by a blinded observer. At 3 mo, mean vessel scores were significantly higher in the RT1u.A-immunized versus class II-immunized and control groups (P <0.05). By 6 mo, there was progression of chronic allograft vasculopathy and a significantly higher mean vessel score in the RT1u.A- and RT1u.D-immunized versus RT1U.B and control groups (P <0.05). In vitro studies show evidence of shifting MHC allopeptide immunogenicity. It was concluded that T cells primed by specific donor class I and II MHC allopeptides promote the development of chronic vascularized allograft rejection. These novel observations provide definitive evidence of a link between indirect allorecognition and the development and progression of chronic rejection.

Original languageEnglish (US)
Pages (from-to)2500-2506
Number of pages7
JournalJournal of the American Society of Nephrology
Volume12
Issue number11
StatePublished - 2001
Externally publishedYes

Fingerprint

Major Histocompatibility Complex
Allografts
Transplants
Peptides
HLA-DQ Antigens
Control Groups
HLA-A Antigens
Freund's Adjuvant
Elastin
HLA-DR Antigens
Immunosuppression
Cyclosporine
Coloring Agents
Transplantation
T-Lymphocytes

ASJC Scopus subject areas

  • Nephrology

Cite this

Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. / Womer, K. L.; Stone, J. R.; Murphy, B.; Chandraker, A.; Sayegh, M. H.

In: Journal of the American Society of Nephrology, Vol. 12, No. 11, 2001, p. 2500-2506.

Research output: Contribution to journalArticle

@article{9f108cae89a34d4b9e00955c0a46c47f,
title = "Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy",
abstract = "Recent clinical and experimental evidence suggests that indirect allorecognition may promote the development of chronic rejection, but definitive experimental studies are lacking. To study the contribution of indirect allorecognition to chronic rejection, na{\"i}ve Lewis (RT1l) rats were immunized with synthetic Wistar Furth (WF) class II-RT1u.D (HLA-DR-like) or -RT1U.B (HLA-DQ-like) or class I-RT1u.A (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n = 5 to 7/group). Experimental and control animals then acted as recipients of fully mismatched WF vascularized cardiac allografts. Recipients received immunosuppression in the form of cyclosporine at a tapering dose that allows for long-term allograft survival. Animals were sacrificed at either 3 or 6 mo, with allograft arterial luminal occlusion scored on elastin stains by a blinded observer. At 3 mo, mean vessel scores were significantly higher in the RT1u.A-immunized versus class II-immunized and control groups (P <0.05). By 6 mo, there was progression of chronic allograft vasculopathy and a significantly higher mean vessel score in the RT1u.A- and RT1u.D-immunized versus RT1U.B and control groups (P <0.05). In vitro studies show evidence of shifting MHC allopeptide immunogenicity. It was concluded that T cells primed by specific donor class I and II MHC allopeptides promote the development of chronic vascularized allograft rejection. These novel observations provide definitive evidence of a link between indirect allorecognition and the development and progression of chronic rejection.",
author = "Womer, {K. L.} and Stone, {J. R.} and B. Murphy and A. Chandraker and Sayegh, {M. H.}",
year = "2001",
language = "English (US)",
volume = "12",
pages = "2500--2506",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

TY - JOUR

T1 - Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy

AU - Womer, K. L.

AU - Stone, J. R.

AU - Murphy, B.

AU - Chandraker, A.

AU - Sayegh, M. H.

PY - 2001

Y1 - 2001

N2 - Recent clinical and experimental evidence suggests that indirect allorecognition may promote the development of chronic rejection, but definitive experimental studies are lacking. To study the contribution of indirect allorecognition to chronic rejection, naïve Lewis (RT1l) rats were immunized with synthetic Wistar Furth (WF) class II-RT1u.D (HLA-DR-like) or -RT1U.B (HLA-DQ-like) or class I-RT1u.A (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n = 5 to 7/group). Experimental and control animals then acted as recipients of fully mismatched WF vascularized cardiac allografts. Recipients received immunosuppression in the form of cyclosporine at a tapering dose that allows for long-term allograft survival. Animals were sacrificed at either 3 or 6 mo, with allograft arterial luminal occlusion scored on elastin stains by a blinded observer. At 3 mo, mean vessel scores were significantly higher in the RT1u.A-immunized versus class II-immunized and control groups (P <0.05). By 6 mo, there was progression of chronic allograft vasculopathy and a significantly higher mean vessel score in the RT1u.A- and RT1u.D-immunized versus RT1U.B and control groups (P <0.05). In vitro studies show evidence of shifting MHC allopeptide immunogenicity. It was concluded that T cells primed by specific donor class I and II MHC allopeptides promote the development of chronic vascularized allograft rejection. These novel observations provide definitive evidence of a link between indirect allorecognition and the development and progression of chronic rejection.

AB - Recent clinical and experimental evidence suggests that indirect allorecognition may promote the development of chronic rejection, but definitive experimental studies are lacking. To study the contribution of indirect allorecognition to chronic rejection, naïve Lewis (RT1l) rats were immunized with synthetic Wistar Furth (WF) class II-RT1u.D (HLA-DR-like) or -RT1U.B (HLA-DQ-like) or class I-RT1u.A (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n = 5 to 7/group). Experimental and control animals then acted as recipients of fully mismatched WF vascularized cardiac allografts. Recipients received immunosuppression in the form of cyclosporine at a tapering dose that allows for long-term allograft survival. Animals were sacrificed at either 3 or 6 mo, with allograft arterial luminal occlusion scored on elastin stains by a blinded observer. At 3 mo, mean vessel scores were significantly higher in the RT1u.A-immunized versus class II-immunized and control groups (P <0.05). By 6 mo, there was progression of chronic allograft vasculopathy and a significantly higher mean vessel score in the RT1u.A- and RT1u.D-immunized versus RT1U.B and control groups (P <0.05). In vitro studies show evidence of shifting MHC allopeptide immunogenicity. It was concluded that T cells primed by specific donor class I and II MHC allopeptides promote the development of chronic vascularized allograft rejection. These novel observations provide definitive evidence of a link between indirect allorecognition and the development and progression of chronic rejection.

UR - http://www.scopus.com/inward/record.url?scp=0034755841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034755841&partnerID=8YFLogxK

M3 - Article

C2 - 11675428

AN - SCOPUS:0034755841

VL - 12

SP - 2500

EP - 2506

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 11

ER -